InsiderSignal.AI

InsiderSignal.ai

BCRX - Biocryst Pharmaceuticals Inc

Insider Sale by Barnes Alane P (GC)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Barnes Alane P, serving as GC at Biocryst Pharmaceuticals Inc (BCRX), sold 150,000 shares at $9.15 per share, for a total transaction value of $1,372,500.00. Following this transaction, Barnes Alane P now holds 400,703 shares of BCRX.

This sale represents a 27.00% decrease in Barnes Alane P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 2 days after the trade was made.

Biocryst Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Barnes Alane P

GC

Alane P. Barnes is the Chief Legal Officer and Corporate Secretary at BioCryst Pharmaceuticals Inc. (BCRX), a position she has held since 2018, after joining the company in September 2006 as General Counsel and advancing through roles including Corporate Secretary (2007), VP General Counsel & Corporate Secretary (2011), and executive officer (2013).[[1]](https://fintool.com/app/research/companies/BCRX/people/alane-barnes)[[2]](https://www.marketscreener.com/insider/ALANE-BARNES-A0NN2G/) Her responsibilities encompass SEC compliance, corporate governance, intellectual property strategy, licensing, government contracts, and dispute resolution.[[1]](https://fintool.com/app/research/companies/BCRX/people/alane-barnes) As of April 14, 2025, she was 59 years old and owned approximately 412,729 shares (0.2% stake) valued at $4 million as of February 27, 2025; she recently sold 161,680 shares on December 1, 2024.[[1]](https://fintool.com/app/research/companies/BCRX/people/alane-barnes)[[2]](https://www.marketscreener.com/insider/ALANE-BARNES-A0NN2G/)[[5]](https://www.tradingview.com/news/tradingview:1e725b8117c65:0-biocryst-pharmaceuticals-officer-sells-over-161k-shares/) Barnes earned a J.D. magna cum laude from Cumberland School of Law at Samford University (1997) and a B.S. in Natural Science from the University of Alabama at Birmingham (UAB).[[1]](https://fintool.com/app/research/companies/BCRX/people/alane-barnes)[[2]](https://www.marketscreener.com/insider/ALANE-BARNES-A0NN2G/) Prior to BioCryst, she managed IP portfolios, licensing transactions, and company spinouts at the UAB Research Foundation, worked as a corporate lawyer at a Birmingham law firm, served as Senior Licensing Associate at the University of Alabama, and held board positions with the Biotechnology Association of Alabama and Alabama Launchpad.[[1]](https://fintool.com/app/research/companies/BCRX/people/alane-barnes)[[2]](https://www.marketscreener.com/insider/ALANE-BARNES-A0NN2G/) Currently, she is a Board Member and Director/Vice President at the Association of Corporate Counsel Research Triangle Area and speaks at industry conferences on pharmaceutical business and women's leadership.[[1]](https://fintool.com/app/research/companies/BCRX/people/alane-barnes)[[2]](https://www.marketscreener.com/insider/ALANE-BARNES-A0NN2G/)[[4]](https://www.acc.com/chapters-networks/chapters/research-triangle-area/our-leadership)

View full insider profile →

Trade Price

$9.15

Quantity

150,000

Total Value

$1,372,500.00

Shares Owned

400,703

Trade Date

Monday, March 16, 2026

7 days ago

SEC Filing Date

Wednesday, March 18, 2026

Filed 2 days after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Biocryst Pharmaceuticals Inc

Company Overview

No company information available
View news mentioning BCRX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4896062

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime